Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Dyslipidemia in HIV-infected individuals: from pharmacogenetics to pharmacogenomics.

Pharmacogenomics - 1 Apr 2010

Tarr Philip E, Rotger Margalida, Telenti Amalio

Abstract excerpt

HIV-infected individuals may have accelerated atherogenesis and an increased risk for premature coronary artery disease. Dyslipidemia represents a key pro-atherogenic mechanism. In HIV-infected patients, dyslipidemia is typically attributed to the adverse effects of antiretroviral therapy. Nine recent genome-wide association studies have afforded a comprehensive, unbiased inventory of common SNPs at 36 genetic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Coronary Artery Disease
Share to Diabetes Mellitus

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Dyslipidemias

Share to Genome, Human

Share to HIV Infections

Share to Lipids

Share to Pharmacogenetics

Source

Identifiers

PMID: 20350140
DOI: 10.2217/pgs.10.35

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Dyslipidemia in HIV-infected individuals: from pharmacogenetics to pharmacogenomics.PMID 20350140Read ↗

Contribution of genome-wide significant single-nucleotide polymorphisms and antiretroviral therapy to dyslipidemia in HIV-infected individuals: a longitudinal study.Semantic proximity Read ↗

Genetic architecture of cardiometabolic risks in people living with HIVSemantic proximity Read ↗

Association of single nucleotide polymorphisms with dyslipidemia in antiretroviral exposed HIV patients in a Ghanaian population: A case-control study.Semantic proximity Read ↗

Impact of genetic factors on dyslipidemia in HIV-infected patients starting antiretroviral therapy.Semantic proximity Read ↗

Association of Single Nucleotide Polymorphisms with Dyslipidemia in Antiretroviral Exposed HIV Patients in a Ghanaian populationSemantic proximity Read ↗

Contribution of 20 single nucleotide polymorphisms of 13 genes to dyslipidemia associated with antiretroviral therapy.Semantic proximity Read ↗

Contribution of genetic background, traditional risk factors, and HIV-related factors to coronary artery disease events in HIV-positive persons.Semantic proximity Read ↗

Impact of genetic polymorphisms on the risk of lipid disorders in patients on anti-HIV therapy.Semantic proximity Read ↗

Pharmacogenetics of the metabolic disturbances and atherosclerosis associated with antiretroviral therapy in HIV-infected patients.Semantic proximity Read ↗

Association between polymorphisms in genes involved in lipid metabolism and immunological status in chronically HIV-infected patients.Semantic proximity Read ↗

Genetic and molecular landscape of comorbidities in people living with HIVSemantic proximity Read ↗

Polymorphisms in LPL, CETP, and HL protect HIV-infected patients from atherogenic dyslipidemia in an allele-dose-dependent manner.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.